Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 651

1.

Time to progression of mantle cell lymphoma after high-dose cytarabine-based regimens defines patients risk for death.

Visco C, Tisi MC, Evangelista A, Di Rocco A, Zoellner AK, Zilioli VR, Hohaus S, Sciarra R, Re A, Tecchio C, Chiappella A, Morello L, Gini G, Nassi L, Perrone T, Molinari AL, Fabbri A, Cox MC, Finolezzi E, Ferrero S, Puccini B, Alvarez De Celis I, Arcari A, Marino D, Merli M, Piazza F, Gentile M, Pelosini M, Loseto G, Hermine O, Dreyling M, Ruggeri M, Martelli M, Hoster E, Vitolo U; Fondazione Italiana Linfomi and the Mantle Cell Lymphoma Network.

Br J Haematol. 2018 Nov 8. doi: 10.1111/bjh.15643. [Epub ahead of print] No abstract available.

PMID:
30407625
2.

Validation of the BAP-65 score for prediction of in-hospital death or use of mechanical ventilation in patients presenting to the emergency department with an acute exacerbation of COPD: a retrospective multi-center study from the Italian Society of Emergency Medicine (SIMEU).

Germini F, Veronese G, Marcucci M, Coen D, Ardemagni D, Montano N, Fabbri A; SIMEU Study Group.

Eur J Intern Med. 2018 Oct 31. pii: S0953-6205(18)30411-4. doi: 10.1016/j.ejim.2018.10.018. [Epub ahead of print]

PMID:
30391167
3.

Best practices for the management of thymic epithelial tumors: A position paper by the Italian collaborative group for ThYmic MalignanciEs (TYME).

Imbimbo M, Ottaviano M, Vitali M, Fabbri A, Leuzzi G, Fiore M, Franceschini D, Pasello G, Perrino M, Schiavon M, Pruneri G, Dei Tos AP, Sangalli C, Garassino MC, Berardi R, Alessi A, Calareso G, Petrini I, Scorsetti M, Scotti V, Rosso L, Rea F, Pastorino U, Casali PG, Ramella S, Ricardi U, Abate-Daga L, Torri V, Trama A, Palmieri G, Marino M, Zucali PA; TYME network collaborators.

Cancer Treat Rev. 2018 Oct 5;71:76-87. doi: 10.1016/j.ctrv.2018.10.001. [Epub ahead of print] Review.

PMID:
30366202
4.

The Influence of Industry Sponsorship on the Research Agenda: A Scoping Review.

Fabbri A, Lai A, Grundy Q, Bero LA.

Am J Public Health. 2018 Nov;108(11):e9-e16. doi: 10.2105/AJPH.2018.304677. Epub 2018 Sep 25.

5.

Efficacy and safety of rituximab plus bendamustine for gastric marginal zone lymphoma.

Cencini E, Fabbri A, Schiattone L, Bocchia M.

Leuk Lymphoma. 2018 Sep 20:1-3. doi: 10.1080/10428194.2018.1504938. [Epub ahead of print] No abstract available.

PMID:
30234387
6.

Study of gene polymorphisms as predictors of treatment efficacy and toxicity in patients with indolent non-hodgkin lymphomas and mantle cell lymphoma receiving bendamustine and rituximab.

Cencini E, Sicuranza A, Fabbri A, Ferrigno I, Rigacci L, Cox MC, Raspadori D, Bocchia M.

Br J Haematol. 2018 Sep 11. doi: 10.1111/bjh.15582. [Epub ahead of print]

PMID:
30203425
7.

Food industry sponsorship of academic research: investigating commercial bias in the research agenda.

Fabbri A, Holland TJ, Bero LA.

Public Health Nutr. 2018 Aug 30:1-9. doi: 10.1017/S1368980018002100. [Epub ahead of print]

PMID:
30157979
8.

T-DM1 and brain metastases: Clinical outcome in HER2-positive metastatic breast cancer.

Fabi A, Alesini D, Valle E, Moscetti L, Caputo R, Caruso M, Carbognin L, Ciccarese M, La Verde N, Arpino G, Cannita K, Paris I, Santini D, Montemurro F, Russillo M, Ferretti G, Filippelli G, Rossello R, Fabbri A, Zambelli A, Leonardi V, D'Ottavio AM, Nisticò C, Stani S, Giampaglia M, Scandurra G, Catania G, Malaguti P, Giannarelli D, Cognetti F.

Breast. 2018 Oct;41:137-143. doi: 10.1016/j.breast.2018.07.004. Epub 2018 Jul 12.

PMID:
30092500
9.

RANBP9 affects cancer cells response to genotoxic stress and its overexpression is associated with worse response to platinum in NSCLC patients.

Tessari A, Parbhoo K, Pawlikowski M, Fassan M, Rulli E, Foray C, Fabbri A, Embrione V, Ganzinelli M, Capece M, Campbell MJ, Broggini M, La Perle K, Farina G, Cole S, Marabese M, Hernandez M, Amann JM, Pruneri G, Carbone DP, Garassino MC, Croce CM, Palmieri D, Coppola V.

Oncogene. 2018 Aug 3. doi: 10.1038/s41388-018-0424-8. [Epub ahead of print]

PMID:
30076413
10.

RELEVENT Trial: Phase II Trial of Ramucirumab, Carboplatin, and Paclitaxel in Previously Untreated Thymic Carcinoma/B3 Thymoma With Area of Carcinoma.

Imbimbo M, Vitali M, Fabbri A, Ottaviano M, Pasello G, Petrini I, Palmieri G, Berardi R, Zucali P, Ganzinelli M, Marabese M, Broggini M, Marino M, Trama A, Rulli E, Hollander L, Pruneri G, Torri V, Garassino MC.

Clin Lung Cancer. 2018 Sep;19(5):e811-e814. doi: 10.1016/j.cllc.2018.06.005. Epub 2018 Jul 3.

PMID:
30033090
11.

How do health consumer organisations in Australia manage pharmaceutical industry sponsorship? A cross-sectional study.

Lau E, Fabbri A, Mintzes B.

Aust Health Rev. 2018 Jul 19. doi: 10.1071/AH17288. [Epub ahead of print]

PMID:
30021681
12.

Liver biochemical abnormalities in Turner syndrome: A comprehensive characterization of an adult population.

Calanchini M, Moolla A, Tomlinson JW, Cobbold JF, Grossman A, Fabbri A, Turner HE.

Clin Endocrinol (Oxf). 2018 Nov;89(5):667-676. doi: 10.1111/cen.13811. Epub 2018 Aug 19.

PMID:
29992593
13.

Primary CNS lymphoma: latest updates and a 10-year monocenter experience.

Cencini E, Fabbri A, Schiattone L, Cerase A, Bocchia M.

Blood Res. 2018 Jun;53(2):174-177. doi: 10.5045/br.2018.53.2.174. Epub 2018 Jun 25. No abstract available.

14.

MYC protein expression scoring and its impact on the prognosis of aggressive B-cell lymphoma patients.

Ambrosio MR, Lazzi S, Lo Bello G, Santi R, Del Porro L, de Santi MM, Guazzo R, Mundo L, Rigacci L, Kovalchuck S, Onyango N, Fabbri A, Cencini E, Zinzani PL, Zaja F, Angrilli F, Stelitano C, Cabras MG, Spataro G, Bob R, Menter T, Granai M, Cevenini G, Naresh KN, Stein H, Sabattini E, Leoncini L.

Haematologica. 2018 Jun 28. pii: haematol.2018.195958. doi: 10.3324/haematol.2018.195958. [Epub ahead of print] No abstract available.

15.

Sunshine Policies and Murky Shadows in Europe: Disclosure of Pharmaceutical Industry Payments to Health Professionals in Nine European Countries.

Fabbri A, Santos A, Mezinska S, Mulinari S, Mintzes B.

Int J Health Policy Manag. 2018 Mar 14;7(6):504-509. doi: 10.15171/ijhpm.2018.20.

16.

The Bacterial Protein CNF1 as a Potential Therapeutic Strategy against Mitochondrial Diseases: A Pilot Study.

Fabbri A, Travaglione S, Maroccia Z, Guidotti M, Pierri CL, Primiano G, Servidei S, Loizzo S, Fiorentini C.

Int J Mol Sci. 2018 Jun 21;19(7). pii: E1825. doi: 10.3390/ijms19071825.

17.

Reporting bias in the literature on the associations of health-related behaviors and statins with cardiovascular disease and all-cause mortality.

Rezende LFM, Rey-López JP, Sá TH, Chartres N, Fabbri A, Powell L, Stamatakis E, Bero L.

PLoS Biol. 2018 Jun 18;16(6):e2005761. doi: 10.1371/journal.pbio.2005761. eCollection 2018 Jun.

18.

Cell Propagation of Cholera Toxin CTA ADP-Ribosylating Factor by Exosome Mediated Transfer.

Zanetti C, Gallina A, Fabbri A, Parisi S, Palermo A, Fecchi K, Boussadia Z, Carollo M, Falchi M, Pasquini L, Fiani ML, Sargiacomo M.

Int J Mol Sci. 2018 May 19;19(5). pii: E1521. doi: 10.3390/ijms19051521.

19.

Rituximab plus bendamustine as front-line treatment in frail elderly (>70 years) patients with diffuse large B-cell non-Hodgkin lymphoma: a phase II multicenter study of the Fondazione Italiana Linfomi.

Storti S, Spina M, Pesce EA, Salvi F, Merli M, Ruffini A, Cabras G, Chiappella A, Angelucci E, Fabbri A, Liberati AM, Tani M, Musuraca G, Molinari A, Petrilli MP, Palladino C, Ciancia R, Ferrario A, Gasbarrino C, Monaco F, Fraticelli V, De Vellis A, Merli F, Luminari S.

Haematologica. 2018 Aug;103(8):1345-1350. doi: 10.3324/haematol.2017.186569. Epub 2018 May 10.

20.

The Bacterial Toxin CNF1 Induces Activation and Maturation of Human Monocyte-Derived Dendritic Cells.

Gall-Mas L, Fabbri A, Namini MRJ, Givskov M, Fiorentini C, Krejsgaard T.

Int J Mol Sci. 2018 May 8;19(5). pii: E1408. doi: 10.3390/ijms19051408.

21.

New therapeutics from Nature: The odd case of the bacterial cytotoxic necrotizing factor 1.

Maroccia Z, Loizzo S, Travaglione S, Frank C, Fabbri A, Fiorentini C.

Biomed Pharmacother. 2018 May;101:929-937. doi: 10.1016/j.biopha.2018.02.140. Epub 2018 Mar 22. Review.

PMID:
29635902
22.

Author Correction: Establishment of patient derived xenografts as functional testing of lung cancer aggressiveness.

Moro M, Bertolini G, Caserini R, Borzi C, Boeri M, Fabbri A, Leone G, Gasparini P, Galeone C, Pelosi G, Roz L, Sozzi G, Pastorino U.

Sci Rep. 2018 Feb 27;8(1):3965. doi: 10.1038/s41598-018-21279-z.

23.

Integrated Cancer Treatment in the Course of Metastatic Pancreatic Cancer: Complete Resolution in 2 Cases.

Bonucci M, Pastore C, Ferrera V, Fiorentini C, Fabbri A.

Integr Cancer Ther. 2018 Sep;17(3):994-999. doi: 10.1177/1534735418755479. Epub 2018 Feb 25.

24.

Potential use of ricotta cheese whey for the production of lactobionic acid by Pseudomonas taetrolens strains.

De Giorgi S, Raddadi N, Fabbri A, Gallina Toschi T, Fava F.

N Biotechnol. 2018 May 25;42:71-76. doi: 10.1016/j.nbt.2018.02.010. Epub 2018 Feb 21.

PMID:
29476816
25.

Does industry-sponsored education foster overdiagnosis and overtreatment of depression, osteoporosis and over-active bladder syndrome? An Australian cohort study.

Mintzes B, Swandari S, Fabbri A, Grundy Q, Moynihan R, Bero L.

BMJ Open. 2018 Feb 13;8(2):e019027. doi: 10.1136/bmjopen-2017-019027.

26.

COPD exacerbations in the emergency department: Epidemiology and related costs. A retrospective cohort multicentre study from the Italian Society of Emergency Medicine (SIMEU).

Germini F, Veronese G, Marcucci M, Coen D, Ardemagni D, Montano N, Fabbri A; SIMEU Study Group.

Eur J Intern Med. 2018 May;51:74-79. doi: 10.1016/j.ejim.2018.01.010. Epub 2018 Jan 20.

PMID:
29371059
27.

Long-term efficacy and toxicity of rituximab plus fludarabine and mitoxantrone (R-FM) for gastric marginal zone lymphoma: a single-center experience and literature review.

Cencini E, Fabbri A, Lauria F, Bocchia M.

Ann Hematol. 2018 May;97(5):821-829. doi: 10.1007/s00277-018-3243-7. Epub 2018 Jan 16. Review.

PMID:
29340761
28.

The Risk of Deterioration in GCS13-15 Patients with Traumatic Brain Injury Identified by Computed Tomography Imaging: A Systematic Review and Meta-Analysis.

Marincowitz C, Lecky FE, Townend W, Borakati A, Fabbri A, Sheldon TA.

J Neurotrauma. 2018 Mar 1;35(5):703-718. doi: 10.1089/neu.2017.5259. Epub 2018 Jan 11.

29.

Preclinical Antileukemia Activity of Tramesan: A Newly Identified Bioactive Fungal Metabolite.

Ricciardi MR, Licchetta R, Mirabilii S, Scarpari M, Parroni A, Fabbri AA, Cescutti P, Reverberi M, Fanelli C, Tafuri A.

Oxid Med Cell Longev. 2017;2017:5061639. doi: 10.1155/2017/5061639. Epub 2017 Nov 15.

30.

Durable response after VNCOP-B and rituximab in an elderly patient with high-grade B-cell lymphoma.

Cencini E, Fabbri A, Schiattone L, Gentili F, Mazzei MA, Bocchia M.

Acta Clin Belg. 2017 Dec 6:1-5. doi: 10.1080/17843286.2017.1412888. [Epub ahead of print]

PMID:
29212420
31.

Estimating the risk of severe hypoglycemic event related to glucose-lowering treatment among Italian patients with diabetes: the HYPOTHESIS database.

Mazzi S, Ravasio R, Forlani G, Veronese G, Fabbri A, Marchesini G.

Clinicoecon Outcomes Res. 2017 Nov 21;9:711-720. doi: 10.2147/CEOR.S148368. eCollection 2017.

32.

Bilateral Parotid Gland Metastases from Gastric Signet-Ring Cell Carcinoma.

Nichetti F, Morano F, Fabbri A, de Braud F, Di Bartolomeo M.

Tumori. 2017 Nov 1:tj5000690. doi: 10.5301/tj.5000690. [Epub ahead of print]

PMID:
29192740
33.

Position paper on vegetarian diets from the working group of the Italian Society of Human Nutrition.

Agnoli C, Baroni L, Bertini I, Ciappellano S, Fabbri A, Papa M, Pellegrini N, Sbarbati R, Scarino ML, Siani V, Sieri S.

Nutr Metab Cardiovasc Dis. 2017 Dec;27(12):1037-1052. doi: 10.1016/j.numecd.2017.10.020. Epub 2017 Oct 31. Review.

34.

High yield purification and first structural characterization of the full-length bacterial toxin CNF1.

Colarusso A, Caterino M, Fabbri A, Fiorentini C, Vergara A, Sica F, Parrilli E, Tutino ML.

Biotechnol Prog. 2018 Jan;34(1):150-159. doi: 10.1002/btpr.2574. Epub 2017 Nov 14.

PMID:
29063721
35.

Whole-brain radiotherapy or autologous stem-cell transplantation as consolidation strategies after high-dose methotrexate-based chemoimmunotherapy in patients with primary CNS lymphoma: results of the second randomisation of the International Extranodal Lymphoma Study Group-32 phase 2 trial.

Ferreri AJM, Cwynarski K, Pulczynski E, Fox CP, Schorb E, La Rosée P, Binder M, Fabbri A, Torri V, Minacapelli E, Falautano M, Ilariucci F, Ambrosetti A, Roth A, Hemmaway C, Johnson P, Linton KM, Pukrop T, Sønderskov Gørløv J, Balzarotti M, Hess G, Keller U, Stilgenbauer S, Panse J, Tucci A, Orsucci L, Pisani F, Levis A, Krause SW, Schmoll HJ, Hertenstein B, Rummel M, Smith J, Pfreundschuh M, Cabras G, Angrilli F, Ponzoni M, Deckert M, Politi LS, Finke J, Reni M, Cavalli F, Zucca E, Illerhaus G; International Extranodal Lymphoma Study Group (IELSG).

Lancet Haematol. 2017 Nov;4(11):e510-e523. doi: 10.1016/S2352-3026(17)30174-6. Epub 2017 Oct 17.

PMID:
29054815
36.

Radiotherapy plus rituximab as first-line regimen for localized follicular lymphoma.

Cencini E, Puccini B, Rigacci L, Fabbri A, Kovalchuk S, Mannelli L, Benelli G, Carfagno T, Simontacchi G, Bocchia M, Bosi A.

Leuk Lymphoma. 2018 Jun;59(6):1420-1426. doi: 10.1080/10428194.2017.1387909. Epub 2017 Oct 10.

PMID:
28994343
37.

Anthropometric, clinical and molecular determinants of treatment outcomes in postmenopausal, hormone receptor positive metastatic breast cancer patients treated with fulvestrant: Results from a real word setting.

Pizzuti L, Natoli C, Gamucci T, Mauri M, Sergi D, Di Lauro L, Paoletti G, Ruggeri E, Iezzi L, Sperduti I, Mentuccia L, Fabbri A, Maugeri-Saccà M, Moscetti L, Barba M, Vici P.

Oncotarget. 2017 Apr 9;8(40):69025-69037. doi: 10.18632/oncotarget.16982. eCollection 2017 Sep 15.

38.

Efficacy and safety of T-DM1 in the 'common-practice' of HER2+ advanced breast cancer setting: a multicenter study.

Fabi A, De Laurentiis M, Caruso M, Valle E, Moscetti L, Santini D, Cannita K, Carbognin L, Ciccarese M, Rossello R, Arpino G, Leonardi V, Montemurro F, La Verde N, Generali D, Zambelli A, Scandurra G, Russillo M, Paris I, D'Ottavio AM, Filippelli G, Giampaglia M, Stani S, Fabbri A, Alesini D, Cianniello D, Giannarelli D, Cognetti F.

Oncotarget. 2017 Mar 18;8(38):64481-64489. doi: 10.18632/oncotarget.16373. eCollection 2017 Sep 8.

39.

Testicular and thyroid function as survival predictors in the elderly patient candidate to surgery.

Aversa A, Fabbri A.

Monaldi Arch Chest Dis. 2017 Jul 18;87(2):841. doi: 10.4081/monaldi.2017.841.

40.

Uncommon somatic mutations in metastatic NUT midline carcinoma.

Cavalieri S, Stathis A, Fabbri A, Sonzogni A, Perrone F, Tamborini E, Pelosi G, de Braud F, Platania M.

Tumori. 2017 Nov 15;103(Suppl. 1):e5-e8. doi: 10.5301/tj.5000685.

PMID:
28967088
41.

How health service delivery guides the allocation of major trauma patients in the intensive care units of the inclusive (hub and spoke) trauma system of the Emilia Romagna Region (Italy). A cross-sectional study.

Chieregato A, Volpi A, Gordini G, Ventura C, Barozzi M, Caspani MLR, Fabbri A, Ferrari AM, Ferri E, Giugni A, Marino M, Martino C, Pizzamiglio M, Ravaldini M, Russo E, Trabucco L, Trombetti S, De Palma R.

BMJ Open. 2017 Sep 29;7(9):e016415. doi: 10.1136/bmjopen-2017-016415.

42.

A retrospective multicentric observational study of trastuzumab emtansine in HER2 positive metastatic breast cancer: a real-world experience.

Vici P, Pizzuti L, Michelotti A, Sperduti I, Natoli C, Mentuccia L, Di Lauro L, Sergi D, Marchetti P, Santini D, Magnolfi E, Iezzi L, Moscetti L, Fabbri A, Cassano A, Grassadonia A, Omarini C, Piacentini F, Botticelli A, Bertolini I, Scinto AF, Zampa G, Mauri M, D'Onofrio L, Sini V, Barba M, Maugeri-Saccà M, Rossi E, Landucci E, Tomao S, Alberti AM, Giotta F, Ficorella C, Adamo V, Russo A, Lorusso V, Cannita K, Barni S, Laudadio L, Greco F, Garrone O, Della Giulia M, Marolla P, Sanguineti G, Di Cocco B, Ciliberto G, De Maria R, Gamucci T.

Oncotarget. 2017 May 25;8(34):56921-56931. doi: 10.18632/oncotarget.18176. eCollection 2017 Aug 22.

43.

Impact of Adrenal Steroids on Regulation of Adipose Tissue.

Infante M, Armani A, Mammi C, Fabbri A, Caprio M.

Compr Physiol. 2017 Sep 12;7(4):1425-1447. doi: 10.1002/cphy.c160037. Review.

PMID:
28915330
44.

Study sponsorship and the nutrition research agenda: analysis of cohort studies examining the association between nutrition and obesity.

Fabbri A, Chartres N, Bero LA.

Public Health Nutr. 2017 Dec;20(17):3193-3199. doi: 10.1017/S1368980017002178. Epub 2017 Aug 30.

PMID:
28851466
45.

The significance of serum immunoglobulin paraprotein in diffuse large B-cell lymphoma.

Cox MC, Di Napoli A, Fabbri A, Cencini E, Ruco L.

Br J Haematol. 2018 Sep;182(5):741-742. doi: 10.1111/bjh.14873. Epub 2017 Aug 17. No abstract available.

PMID:
28832947
46.

Establishment of patient derived xenografts as functional testing of lung cancer aggressiveness.

Moro M, Bertolini G, Caserini R, Borzi C, Boeri M, Fabbri A, Leone G, Gasparini P, Galeone C, Pelosi G, Roz L, Sozzi G, Pastorino U.

Sci Rep. 2017 Jul 27;7(1):6689. doi: 10.1038/s41598-017-06912-7. Erratum in: Sci Rep. 2018 Feb 27;8(1):3965.

47.

Lenalidomide and Temozolomide Combination in a Very Elderly Patient with CNS Relapse of Diffuse Large B-Cell Lymphoma.

Cencini E, Fabbri A, Arrigucci U, Cerase A, Bocchia M.

Mediterr J Hematol Infect Dis. 2017 Jun 16;9(1):e2017040. doi: 10.4084/MJHID.2017.040. eCollection 2017.

48.

New perspectives for patients with primary CNS lymphoma.

Fabbri A, Cencini E, Cerase A, Bocchia M.

Radiother Oncol. 2017 Aug;124(2):331-332. doi: 10.1016/j.radonc.2017.04.027. Epub 2017 Jul 4. No abstract available.

PMID:
28687399
49.

A cross-sectional analysis of pharmaceutical industry-funded events for health professionals in Australia.

Fabbri A, Grundy Q, Mintzes B, Swandari S, Moynihan R, Walkom E, Bero LA.

BMJ Open. 2017 Jun 30;7(6):e016701. doi: 10.1136/bmjopen-2017-016701.

50.

Acute Heart Failure in the Emergency Department: the SAFE-SIMEU Epidemiological Study.

Fabbri A, Marchesini G, Carbone G, Cosentini R, Ferrari A, Chiesa M, Bertini A, Rea F; Italian Society of Emergency Medicine (SIMEU).

J Emerg Med. 2017 Aug;53(2):178-185. doi: 10.1016/j.jemermed.2017.03.030. Epub 2017 May 10.

PMID:
28501384

Supplemental Content

Loading ...
Support Center